Acadia Pharmaceuticals Inc (ACAD)

Long-Term Debt

$59.55M

Quarterly · Period ending: · USD

ACAD logo

ACAD Long-Term Debt

Latest reported$59.55M
ACAD Quarterly Long-Term Debt ($1.62M → $59.55M)
High-resolution chart · PNG

ACAD long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
59,547,000
39,003,000
40,554,000
43,026,000
44,601,000
44,634,000
42,037,000
40,421,000
47,186,000
49,189,000
47,800,000
48,103,000
49,778,000
51,441,000
52,695,000
53,769,000
54,693,000
55,478,000
56,126,000
57,677,000
59,134,000
60,581,000
44,460,000
45,343,000
5,669,000
6,090,000
6,361,000
12,758,000
13,484,000
13,508,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,000
41,000
51,000
65,000
98,000
154,000
228,000
324,000
430,000
560,000
730,000
939,000
1,156,000
1,255,000
1,439,000
1,503,000
1,379,000
1,144,000
883,000
733,000
892,000
926,700
818,900
854,000
1,486,400,000
1,026,300,000
946,300
876,500
1,624,100
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.